Cancer Genomics

Why MolecularDx?

Next generation sequencing technologies.

Most cancers result from accumulation of multiple genetic alterations that lead to dysfunction of cancer-associated genes. These genetic alterations are important diagnostic, prognostic, and predictive biologic markers. Next generation sequencing technologies permit deep sequencing of hundreds of cancer genes concurrently.

Our Solid Tumor NGS Panel analyzes a set of key cancer gene mutations including many clinically actionable mutations. The test can provide important individual information regarding tumor development and progression, and a more reliable prediction of personalized cancer therapies.

Our caner panel tests are enhanced by the addition of analysis for gene copy number variations and fusions.

Solid Tumor Gene List

ABL1 ERBB2 GNAQ MYC
AKT1 ERBB4 HRAS MYCN
AKT3 ERBB3 IDH1 NRAS
ALK ERG IDH2 NTRK1
AR ESR1 JAK1 NTRK2
AXL ETV1 JAK2 NTRK3
BRAF ETV4 JAK3 PDGFRA
CCND1 ETV5 KIT PIK3CA
CDK4 FGFR1 KRAS PPARG
CDK6 FGFR2 MAP2K1 RAF1
CTNNB1 FGFR3 MAP2K2 RET
DDR2 FGFR4 MET ROS1
EGFR GNA11 MTOR SMO

Sample Report

Our reports provide a detailed look at a patient's tumor including pathologic interpretation, prognostic features and therapeutic indications. Request a sample report now to see how our Solid Tumor NGS test can provide the oncology answers you're looking for.

Request a Sample Report